Table 1.
Genus | Median log2 RA Cancer |
Median log2 RA Healthy |
Effect size | P value | Padj |
---|---|---|---|---|---|
Corynebacterium | −3.05078 | 0.55456 | 0.93460 | 0.00002 | 0.00024 |
Acinetobacter | 3.52399 | 4.99866 | 0.89468 | 0.00004 | 0.00047 |
Prevotella | −0.07806 | 2.23876 | 0.83597 | 0.00010 | 0.00085 |
Gammaproteobacteria (unclassified) | −3.41404 | 0.24559 | 0.83370 | 0.00022 | 0.00147 |
Prevotella | −2.19046 | 0.61126 | 0.83049 | 0.00048 | 0.00297 |
Lactococcus | 1.80420 | 3.84987 | 0.74354 | 0.00003 | 0.00038 |
Lactococcus | 1.21785 | 3.44230 | 0.72191 | 0.00041 | 0.00267 |
Prevotella | −3.88765 | −1.18212 | 0.67504 | 0.00204 | 0.00919 |
Lactococcus | −0.23240 | 3.06471 | 0.56543 | 0.00320 | 0.01553 |
Prevotella | −3.43107 | −1.36356 | 0.49660 | 0.03067 | 0.08866 |
Streptococcus | −0.77006 | 1.46508 | 0.42017 | 0.04131 | 0.12656 |
Micrococcus | 0.52029 | 1.11744 | 0.36611 | 0.03150 | 0.09472 |
Staphylococcus | −1.35312 | −3.22940 | −0.44771 | 0.03066 | 0.08570 |
Staphylococcus | 2.57149 | 1.37032 | −0.45353 | 0.03536 | 0.11197 |
Lactobacillus | 2.73155 | 1.64036 | −0.47398 | 0.02433 | 0.08437 |
Propionibacterium | 4.31073 | 3.43269 | −0.48797 | 0.03016 | 0.10008 |
Bacillus | −2.22084 | −4.77999 | −0.51615 | 0.02394 | 0.06333 |
Bacillales (unclassified) | −1.45938 | −4.20697 | −0.51839 | 0.01784 | 0.05692 |
Bacillus | −2.39633 | −5.17174 | −0.55899 | 0.01690 | 0.05183 |
Staphylococcus | 1.32550 | −1.53964 | −0.66019 | 0.00057 | 0.00348 |
Bacillus | 1.14347 | −2.40476 | −0.79326 | 0.00020 | 0.00140 |
Gammaproteobacteria (unclassified) | 0.05306 | −3.91697 | −0.98396 | 0.00002 | 0.00020 |
Bacillus | 4.56707 | 0.08631 | −1.32125 | 0.00000 | 0.00000 |
Median log2 relative abundances (RA) and effect sizes of different genera in healthy-normal tissue and tumor-adjacent-normal tissue. Negative effect size value indicates a higher relative abundance of genera in tumor-adjacent-normal tissue compared to healthy-normal tissue.
Bolded values indicate bacterial genera found to significantly differ between the study groups after adjusting for multiple testing.